These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 19010354

  • 1. A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
    Telegina E, Reshetnyak T, Moshnikova A, Proussakova O, Zhukova A, Kuznetsova A, Ivanov A, Paltsev M, Beletsky I.
    Immunol Lett; 2009 Jan 29; 122(1):12-7. PubMed ID: 19010354
    [Abstract] [Full Text] [Related]

  • 2. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E, Puccetti A, Gerli R, Rigo A, Migliorini P, Simeoni S, Beri R, Dolcino M, Martinelli N, Corrocher R, Lunardi C.
    Int Immunol; 2009 Mar 29; 21(3):237-43. PubMed ID: 19181929
    [Abstract] [Full Text] [Related]

  • 3. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 29; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 4. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009 Feb 29; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 5. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun 29; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 6. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 2001 Jun 29; 21(4B):3053-9. PubMed ID: 11712810
    [Abstract] [Full Text] [Related]

  • 7. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ.
    Arch Dermatol Res; 2006 Jan 29; 297(7):329-32. PubMed ID: 16328345
    [Abstract] [Full Text] [Related]

  • 8. Serum sFas/sFasL ratio in systemic lupus erythematosus (SLE) is a function of age.
    Turi MC, D'Urbano M, Celletti E, Alessandri C, Valesini G, Paganelli R.
    Arch Gerontol Geriatr; 2009 Jan 29; 49 Suppl 1():221-6. PubMed ID: 19836636
    [Abstract] [Full Text] [Related]

  • 9. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y.
    Hokkaido Igaku Zasshi; 1997 Jul 29; 72(4):443-55. PubMed ID: 9266252
    [Abstract] [Full Text] [Related]

  • 10. Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signaling.
    Bremer E, Abdulahad WH, de Bruyn M, Samplonius DF, Kallenberg CG, Armbrust W, Brouwers E, Wajant H, Helfrich W.
    Immunol Lett; 2011 Aug 30; 138(2):161-8. PubMed ID: 21514322
    [Abstract] [Full Text] [Related]

  • 11. Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL.
    Martínez-Lorenzo MJ, Anel A, Saez-Gutierrez B, Royo-Cañas M, Bosque A, Alava MA, Piñeiro A, Lasierra P, Asín-Ungría J, Larrad L.
    Clin Immunol; 2007 Jan 30; 122(1):28-40. PubMed ID: 16982214
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F, Siddiqui AA.
    Clin Chim Acta; 2006 Aug 30; 370(1-2):100-7. PubMed ID: 16513103
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
    Pyrovolaki K, Mavroudi I, Sidiropoulos P, Eliopoulos AG, Boumpas DT, Papadaki HA.
    Arthritis Rheum; 2009 Feb 30; 60(2):543-52. PubMed ID: 19180486
    [Abstract] [Full Text] [Related]

  • 14. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ, Ku JK, Kim MY, Kang H, Cho SH, Kim HO, Park YM.
    Br J Dermatol; 2006 Mar 30; 154(3):419-25. PubMed ID: 16445769
    [Abstract] [Full Text] [Related]

  • 15. TNF-α confers resistance to Fas-mediated apoptosis in rheumatoid arthritis through the induction of soluble Fas.
    Hong S, Kim EJ, Lee EJ, San Koo B, Min Ahn S, Bae SH, Lim DH, Kim YG, Yoo B, Lee CK.
    Life Sci; 2015 Feb 01; 122():37-41. PubMed ID: 25529148
    [Abstract] [Full Text] [Related]

  • 16. Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)-mediated apoptosis of T cells.
    Tarr JM, Winyard PG, Ryan B, Harries LW, Haigh R, Viner N, Eggleton P.
    Arthritis Rheum; 2010 Oct 01; 62(10):2919-29. PubMed ID: 20533543
    [Abstract] [Full Text] [Related]

  • 17. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
    Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M.
    Ann Rheum Dis; 2005 Jun 01; 64(6):854-8. PubMed ID: 15564310
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M, Kim D, Oh M, Jeong H, Choi I.
    Lupus; 2009 May 01; 18(6):501-7. PubMed ID: 19395451
    [Abstract] [Full Text] [Related]

  • 19. Levels of soluble Fas/APO-1 in patients with Behçet's disease.
    Hamzaoui K, Hamzaoui A, Zakraoui L, Chabbou A.
    Mediators Inflamm; 1998 May 01; 7(2):111-4. PubMed ID: 9836498
    [Abstract] [Full Text] [Related]

  • 20. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
    Chen DY, Hsieh TY, Hsieh CW, Lin FJ, Lan JL.
    Arthritis Rheum; 2007 Dec 15; 57(8):1530-8. PubMed ID: 18050226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.